CEO and President Ankit Mahadevia sold $207K of Spero Therapeutics, Inc.

Sold$206,709

$14.28Price

14,472Shares

−18%Stake

What SPRO did after the filing

Prices for SPRO after this filing aren't in yet.

Traded Tue, Oct 13. Filed Thu, Oct 15, 4:24 PM ET, after the close. Not investment advice.